Eloxx Pharmaceuticals Inc Shares Fall 5.6% Below Previous 52-Week Low - Market Mover
The shares fell 5.6% lower than its previous 52-week low of $0.56, with trading volume lower than its 30 day average
Jan 15, 2022 by Kwhen Finance Editors
Eloxx Pharmaceuticals Inc (ELOX) shares closed 5.6% lower than its previous 52 week low, giving the company a market cap of $49M. The stock is currently down 19.4% year-to-date, down 85.9% over the past 12 months, and down 77.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%.
Trading Activity
- Trading volume this week was 80.1% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 10.5% lower than its 5-day moving average, 20.9% lower than its 20-day moving average, and 53.9% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals Inc | -6.9 | -19.4 | -85.9 | -88.8 | -0.2 |
| Dow Jones Industrial Average | -0.6 | -0.6 | 18.2 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 23.9 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.5 | 13.0 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -691.8%
- The company's stock price performance over the past 12 months lags the peer average by 552.0%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals Inc | ELOX | 0 | -19.4 | -85.9 | -88.8 | -0.2 |
| Peer Avg | N/A | 4.0 | 3.3 | -13.2 | -21.5 | 16.5 |
| National Research Corp | NRC | 27.3 | -6.9 | -13.6 | -30.7 | -0.1 |
| Nymox Pharmaceutical Corp | NYMX | -11.4 | 20.0 | -39.1 | -55.4 | 66.0 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: